These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 20805208)

  • 1. Vancouver's supervised injection facility challenges Canada's drug laws.
    Dooling K; Rachlis M
    CMAJ; 2010 Sep; 182(13):1440-4. PubMed ID: 20805208
    [No Abstract]   [Full Text] [Related]  

  • 2. Is Vancouver Canada's supervised injection facility cost-saving?
    Pinkerton SD
    Addiction; 2010 Aug; 105(8):1429-36. PubMed ID: 20653622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of Vancouver's supervised injection facility.
    Bayoumi AM; Zaric GS
    CMAJ; 2008 Nov; 179(11):1143-51. PubMed ID: 19015565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility.
    Andresen MA; Boyd N
    Int J Drug Policy; 2010 Jan; 21(1):70-6. PubMed ID: 19423324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report of Advisory Council on the Misuse of Drugs: AIDS and drug misuse update.
    Raistrick D
    Addiction; 1994 Oct; 89(10):1211-3. PubMed ID: 7804081
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluating Vancouver's supervised injection facility: data and dollars, symbols and ethics.
    Des Jarlais DC; Arasteh K; Hagan H
    CMAJ; 2008 Nov; 179(11):1105-6. PubMed ID: 19015552
    [No Abstract]   [Full Text] [Related]  

  • 7. How many HIV infections are prevented by Vancouver Canada's supervised injection facility?
    Pinkerton SD
    Int J Drug Policy; 2011 May; 22(3):179-83. PubMed ID: 21450450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.
    Hyshka E; Strathdee S; Wood E; Kerr T
    Int J Drug Policy; 2012 Jul; 23(4):261-70. PubMed ID: 22579215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Harm reduction in the health care system: the legality of prescribing and dispensing syringes to drug users.
    Burris S; Lurie P; Ng M
    Health Matrix Clevel; 2001; 11(1):5-64. PubMed ID: 11345676
    [No Abstract]   [Full Text] [Related]  

  • 10. Lethal injections: the law, science, and politics of syringe access for injection drug users.
    Burris S; Strathdee SA; Vernick JS
    Univ San Francisco Law Rev; 2003; 37(4):813-85. PubMed ID: 15457636
    [No Abstract]   [Full Text] [Related]  

  • 11. Negotiating place and gendered violence in Canada's largest open drug scene.
    McNeil R; Shannon K; Shaver L; Kerr T; Small W
    Int J Drug Policy; 2014 May; 25(3):608-15. PubMed ID: 24332972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug use and harm reduction policy: alternative perspectives on the California proposal.
    Stauffer L
    J Health Soc Policy; 2004; 19(3):19-36. PubMed ID: 15829451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New drug policies: the Geneva example].
    Mino A
    Psychiatr Enfant; 1994; 37(2):577-99. PubMed ID: 7878141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/AIDS in India. The needle and the damage done.
    Cohen J
    Science; 2004 Apr; 304(5670):509-12. PubMed ID: 15105472
    [No Abstract]   [Full Text] [Related]  

  • 15. Vancouver's supervised injection facility granted constitutional exemption from federal drug law.
    HIV AIDS Policy Law Rev; 2008 Dec; 13(2-3):28-9. PubMed ID: 19294788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing Canada's research base for harm reduction and health equity approaches to HIV prevention and treatment.
    Shoveller J; DeBeck K; Montaner J
    Can J Public Health; 2010; 101(6):442-4. PubMed ID: 21370777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel: emerging issues in Canada's drug policy--implications for HIV prevention and health promotion for people who use drugs.
    Strike C; Elliott R; Nolin C
    HIV AIDS Policy Law Rev; 2009 Dec; 14(2):93-8. PubMed ID: 20225528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying up harm reduction policy: the office as an assemblage.
    Chen JS
    Int J Drug Policy; 2011 Nov; 22(6):471-7. PubMed ID: 22000601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancouver's needle exchange program.
    Bardsley J; Turvey J; Blatherwick J
    Can J Public Health; 1990; 81(1):39-45. PubMed ID: 2311049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genesis of syringe prescription to prevent HIV in Rhode Island.
    Rich JD; McKenzie M; Macalino G; Runnarsdottir V; Gaydos M; Mehrotra M; Stein J; Whitlock T; Salas C; Burris S
    Health Matrix Clevel; 2001; 11(1):129-45. PubMed ID: 11345673
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.